QRS dispersion ≥40 ms was the strongest independent predictor of sudden death in ARVC (P<0.0001), with a sensitivity of 90% and specificity of 77%.
Case-Control (n=80)
Do clinical and ECG findings, specifically QT and QRS dispersion, predict the risk of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy?
QRS dispersion ≥40 ms on a standard ECG is a strong independent predictor of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy, aiding in arrhythmic risk stratification.
p-value: p=<0.0001
BACKGROUND: We retrospectively investigated the value of clinical and ECG findings as well as QT-QRS dispersion in predicting the risk of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). METHODS AND RESULTS: Duration and interlead variability of the QT interval and QRS complex were measured manually from standard ECGs in 20 sudden death victims with ARVC diagnosed at autopsy (group I), in 20 living ARVC patients with sustained ventricular tachycardia (group II), in 20 living ARVC patients with /=40 ms had a sensitivity and specificity of 90% and 77%, respectively; QT dispersion >65 ms, 85% and 75%, respectively; negative T wave beyond V(1), 85% and 42%, respectively; and syncope, 40% and 90%, respectively. CONCLUSIONS: QRS dispersion (>/=40 ms) was the strongest independent predictor of sudden death in ARVC. Syncope, QT dispersion >65 ms, and negative T wave beyond V(1) refined arrhythmic risk stratification in these patients.
Turrini et al. (2001) conducted a case-control in arrhythmogenic right ventricular cardiomyopathy (ARVC) (n=80). QT and QRS dispersion vs. Living ARVC patients and healthy controls was evaluated on sudden death (p=<0.0001). QRS dispersion ≥40 ms was the strongest independent predictor of sudden death in ARVC (P<0.0001), with a sensitivity of 90% and specificity of 77%.